Finance

Lists
Why is 6919 up 2,35%?
Dive Deeper
6919:TPE
Caliway Biopharmaceuticals Co Ltd
78,30 NT$
+2,35%
(+1,80) 1D
14 հոկ, 13:30:06 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6919...
Open
77,90 NT$
High
78,90 NT$
Low
77,40 NT$
Mkt. cap
121,93 մլրդ
Avg. vol.
8,39 մլն
Volume
2,93 մլն
52-wk high
188,00 NT$
52-wk low
75,10 NT$
EPS
-0,17 NT$
Open
77,90 NT$
High
78,90 NT$
Low
77,40 NT$
Mkt. cap
121,93 մլրդ
Avg. vol.
8,39 մլն
Volume
2,93 մլն
52-wk high
188,00 NT$
52-wk low
75,10 NT$
EPS
-0,17 NT$
News stories
From web sources and news partners
About Caliway Biopharmaceuticals Co Ltd
CEO-
Employees-
Founded2012
Headquarters-
Sector-
Websitecaliwaybiopharma.com
Last report
11 օգս, 2026 թ.
Fiscal period
Q2 2026
-0,14 NT$ / 2,93 NT$
-104,78%miss
Revenue / Est. (TWD)
3,57 մլն / 6,01 մլրդ
-99,94%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
13,42 մլն
12,41 մլն
2,00 հզր
3,57 մլն
Cost of goods sold
4,09 մլն
3,40 մլն
1,00 հզր
1,24 մլն
Cost of revenue
4,09 մլն
3,40 մլն
1,00 հզր
1,24 մլն
Research and development expenses
244,51 մլն
112,62 մլն
212,41 մլն
210,66 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-33,70 մլն
17,06 մլն
33,42 մլն
54,75 մլն
Operating expense
210,81 մլն
129,69 մլն
245,83 մլն
265,41 մլն
Total operating expenses
214,89 մլն
133,09 մլն
245,83 մլն
266,65 մլն
Operating income
-201,48 մլն
-120,68 մլն
-245,83 մլն
-263,08 մլն
Other non operating income
-280,00 հզր
9,00 հզր
-4,00 հզր
-2,00 հզր
EBT including unusual items
-7,73 մլն
80,19 մլն
-107,75 մլն
-222,52 մլն
EBT excluding unusual items
-7,73 մլն
80,19 մլն
-107,75 մլն
-222,52 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7,73 մլն
80,19 մլն
-107,75 մլն
-222,52 մլն
Net profit margin
-57,62%
646,17%
-5 387 700,00%
-6 239,93%
Earnings per share
-0,01
0,05
-0,07
-0,14
Interest and investment income
59,73 մլն
85,42 մլն
78,51 մլն
82,27 մլն
Interest expense
-34,00 հզր
-22,00 հզր
-11,00 հզր
-329,00 հզր
Net interest expenses
59,70 մլն
85,40 մլն
78,50 մլն
81,94 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-195,81 մլն
-114,79 մլն
-239,81 մլն
-258,15 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps